Work

mTORC1 Selective Nano‐Inhibitor by Disrupting the Lysosomal Arginine‐SLC38A9‐ mTORC1‐CDKs Axis for Precision Bladder Cancer Therapy

Year: 2025

Type: article

Source: Advanced Materials

DOI: 10.1002/adma.202504798

Authors: Lulu Kong, Kaikai Xu, Xinlu Bao, Kebin Ye, Di Fan, Ning Wang, Yongming Deng, Wei Wang, Shaohua Wei, Lin Zhou

Institutions: Nanjing Normal University, Xihua University, Nanjing Drum Tower Hospital, Yancheng Institute of Technology

Language: English

Topic: Nanoplatforms for cancer theranostics

Subfield: Biomedical Engineering

Field: Engineering

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Natural Science Foundation of China, Priority Academic Program Development of Jiangsu Higher Education Institutions

Award: G5985793164

OpenAlex ID: W4412047227

FWCI: 2.369

Cites: 45

Cited by: 10

Related to: 10